HMVSX
Price
$19.71
Change
-$0.16 (-0.81%)
Updated
Sep 20 closing price
VMVAX
Price
$86.17
Change
-$0.37 (-0.43%)
Updated
Sep 20 closing price
Ad is loading...

HMVSX vs VMVAX

Header iconHMVSX vs VMVAX Comparison
Open Charts HMVSX vs VMVAXBanner chart's image
Hartford MidCap Value R4
Price$19.71
Change-$0.16 (-0.81%)
VolumeN/A
CapitalizationN/A
Vanguard Mid-Cap Value Index Admiral
Price$86.17
Change-$0.37 (-0.43%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
HMVSX vs VMVAX Comparison Chart
Loading...
VS
HMVSX vs. VMVAX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HMVSX is a Buy and VMVAX is a StrongBuy.

FUNDAMENTALS
Fundamentals
VMVAX has more cash in the bank: 30.5B vs. HMVSX (1.08B). VMVAX pays higher dividends than HMVSX: VMVAX (2.14) vs HMVSX (0.35). HMVSX was incepted earlier than VMVAX: HMVSX (14 years) vs VMVAX (13 years). HMVSX is a more actively managed with annual turnover of: 84.00 vs. VMVAX (22.00). HMVSX has a lower initial minimum investment than VMVAX: HMVSX (0) vs VMVAX (3000). VMVAX annual gain was more profitable for investors over the last year : 25.35 vs. HMVSX (17.29). VMVAX return over 5 years is better than : 48.82 vs. HMVSX (29.48).
HMVSXVMVAXHMVSX / VMVAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence14 years13 years-
Gain YTD11.98914.94680%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets1.08B30.5B4%
Annual Yield % from dividends0.352.1416%
Returns for 1 year17.2925.3568%
Returns for 3 years7.2620.7135%
Returns for 5 years29.4848.8260%
Returns for 10 years15.10100.8815%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AUUD0.790.01
+0.67%
Auddia
CTLT60.00-0.11
-0.18%
CATALENT
JAMF18.49-0.09
-0.48%
Jamf Holding Corp
ARCT20.61-0.41
-1.95%
Arcturus Therapeutics Holdings
ANVS8.47-0.17
-1.97%
Annovis Bio